Evolent Health, Inc. (EVH) Return on equity 2016–2025
Evolent Health, Inc. (EVH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-139.5%FY2025 · since FY2016: -22.7% → -139.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -139.5% | -130.2 pp |
| FY2024 | -9.3% | +4.0 pp |
| FY2023 | -13.3% | -11.1 pp |
| FY2022 | -2.2% | +3.2 pp |
| FY2021 | -5.4% | +48.5 pp |
| FY2020 | -53.9% | -21.4 pp |
| FY2019 | -32.5% | -27.9 pp |
| FY2018 | -4.6% | +1.4 pp |
| FY2017 | -6.0% | +16.7 pp |
| FY2016 | -22.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice